Source link : https://www.newshealth.biz/health-news/novel-treatment-alleviates-postherpetic-neuralgia/
TOPLINE: Crisugabalin — an oral calcium channel alpha 2 delta-1 subunit ligand — was safe and well-tolerated at doses of 40 mg/d and 80 mg/d and significantly reduced pain scores in patients with postherpetic neuralgia (PHN) over 12 weeks in a phase 3 study. METHODOLOGY: Researchers conducted a phase 3 multicenter, double-blind study involving 366 […]
Author : News Health
Publish date : 2024-10-07 06:38:08
Copyright for syndicated content belongs to the linked Source.
inHealth